Scottish Mortgage Investment Trust PLC is an actively managed, low-cost investment trust, investing in a high-conviction global portfolio of companies, with the aim of maximising total returns over the long term. The managers look for strong businesses with above-average returns and aim to achieve a greater return than the FTSE All-World Index (in sterling terms) over a five-year rolling period.

I invest on my own behalf, am a job seeker, a journalist or want to learn more about Baillie Gifford.

If none of the previous options apply, please select Rest of World below:

SELECT LOCATION

This article is archived and some details may be out of date.

You need to be an existing investor of this {{FundOrStrategy}} before you can view its details.
If you are not an existing investor of this {{FundOrStrategy}}, please close this message and you'll be directed to our list of funds.

Home

This private website has been shared on a reverse solicitation basis only. It is intended to only be accessed by the recipient: a professional or institutional investor who has received the direct link from Baillie Gifford following a reverse enquiry. It has been designed to provide you with the specific information you have requested from Baillie Gifford. It is not for onward distribution, and is not intended for use with retail clients.

Legal declaration

This podcast is archived and some details may be out of date.

This video is archived and some details may be out of date.

Philosophy

Deliberately different in more ways than one. Discover our investment philosophy and learn how we differentiate ourselves from the rest.

Insights

Explainers

Documents

Podcast

You are viewing the site as Individual Investors in UK

About Us

How to Invest

Frequently Asked Questions

Three glass vaccine vials labelled COVID-19 Vaccine Moderna.

#05063a

mRNA has transformational potential by pioneering a new class of medicines that leverage the body’s natural protein production apparatus to treat diseases.
Moderna has laid the foundations to scale drug development, an ambition that sets it apart from other biotech companies.
The company has a diverse pipeline looking for cures for the four ‘big killers’ – cardiovascular disease, cancer, infectious diseases and autoimmune diseases.

Chair Noubar Afeyan co-founded Moderna via Flagship Pioneering in 1999. Flagship Pioneering is revolutionising the entrepreneurial process in biotech by linking fundamental research with business expertise and investment.

Moderna

What does it do?

Why do we invest?

Who is key?

Moderna: designing drugs on a computer

Moderna: from Covid vaccines to cancer cures

From Covid to cancer: Moderna’s new challenge

It's in their DNA

When

Where

Listing status